2015-05-04 17:59:38 UTC

Registration Still Open for 2015 AGA SPGC

May 4, 2015

There's still time to register for the 2015 postgraduate course, which is scheduled for May 16 and 17 in Washington, DC.

New treatment advances will be presented at the 2015 AGA Spring Postgraduate Course: Evidence That Will Change Your Practice: New Advances for Common Clinical Problems. The course is scheduled for May 16 and 17, 2015, during Digestive Disease Week® (DDW) in Washington, DC. 

In the DDW Daily News advance issue, Douglas A. Corley, MD, PhD, MPH, course director, explains why you should attend this course.

“There have been a number of advances that affect large numbers of our patients in recent years that have been confusing, contradictory and changing so quickly that it becomes challenging to absorb all of the new treatment alternatives. In this course, we are aiming to provide concise summaries to guide therapy by having experts sort through recently published data as well as late-breaking studies which are still in abstract or pre-publication form.”

The course offers up to 12 AMA PRA Category 1 Credits™ and, pending approval, 8 American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) points. Registration is still open — secure your spot today.

More on Barrett's Esophagus

Porcine Esophageal Submucosal Gland Culture Model Shows Capacity for Proliferation and Differentiation

Oct. 22, 2017

We describe a novel porcine 3-dimensional culture model that reproduces esophageal submucosal gland proliferation in vivo associated with cancer and injury.

Late Recurrence of Barrett’s Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial

Sept. 1, 2017

Endoscopic surveillance of patients with BE treated with radiofrequency ablation will likely be of diminishing value as the time since ablation grows.

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett’s Esophagus With a Minimally Invasive Cell Sampling Device

Sept. 1, 2017

We found Cytosponge screening with endoscopic confirmation to be a cost-effective strategy.